L'Oréal partners up with Verily, which is owned by Alphabet, to conduct "skin health" research programmes
22 January 2022, Mumbai:
L'Oréal, the world's largest cosmetics firm, announced a collaboration with Verily, the health section of Alphabet, the parent company of Google, to establish research programmes on "skin health" on Thursday.
According to L'Oréal, this relationship is "the first of its type in the cosmetics business," and it will result in "two programmes targeted at better understanding and interpreting the processes of hair and skin aging," as stated in a press statement issued on Thursday.
The first of these programmes combines L'Oréal's scientific expertise in skincare with Verily's experience in digital data.
The objective is to figure out how skin aging, deep skin biology, and the entire collection of environmental elements that a person is exposed to throughout their life are linked (known as the exposome in scientific language).
According to L'Oréal, the second programme intends to build a computerized diagnosis service for healthcare practitioners.
L'Oréal and Verily will rely on "the development of new technologies and tele-diagnosis solutions, such as sensors and artificial intelligence algorithms applied to dermatology and skin care," as well as "the development of new technologies and tele-diagnosis solutions, such as sensors and artificial intelligence algorithms applied to dermatology and skin care."
"Through this partnership, we hope to usher in a new era of skin health, allowing everyone around the world to benefit from the most inclusive, personalized, powerful, and precise programmes for their skin at every stage of their lives," said Nicolas Hieronimus, CEO of the L'Oréal group, in a press release.
According to L'Oréal, 1.9 billion people worldwide suffer from skin illnesses (eczema, psoriasis, skin cancer, acne, and more), and access to dermatologists is often difficult.
"Both Verily and L'Oréal believe in the revolutionary power of technology to allow precise beauty and wellness," said Verily's president and COO, Stephen Gillett.
"Powered by Verily's technology and clinical science abilities combined with L'Oréal's beauty industry-leading intelligence and dermatology network, our collective approach has the potential to identify the right intervention based on data," said Brian Otis, co-founder of Verily, who was also quoted in the press release.
Stay Updated.
Follow us on Linkedin & Youtube.
